Features of Recurrence of Basal Cell Carcinoma of the Scalp
- Authors: Ermakova T.S.1, Topuzov E.E.1, Ershov V.A.1, Kutukova S.I.1
-
Affiliations:
- City Clinical Oncology Dispensary, St. Petersburg, Russia
- Section: Original Study Articles
- Submitted: 21.01.2025
- Accepted: 01.09.2025
- Published: 03.09.2025
- URL: https://rjonco.com/1028-9984/article/view/646491
- DOI: https://doi.org/10.17816/onco646491
- EDN: https://elibrary.ru/UFCPUJ
- ID: 646491
Cite item
Abstract
BACKGROUND: Basal cell carcinoma (BCC) is the most common malignant neoplasm in humans. The cause of local recurrence after radical treatment remains unknown.
AIM: The work aimed to identify prognostically significant factors for the development of recurrent basal cell carcinoma of the skin.
METHODS: We analyzed clinicopathological data from 100 cases of BCC, including 50 cases of newly diagnosed basal cell carcinoma of the scalp and 50 cases with recurrent disease.
RESULTS: The incidence of BCC recurrence on the nose was four times higher compared to other localizations. Recurrence on the nasal skin occurred in 21 cases; in 29 patients, recurrence was observed when BCC was localized on the skin of the scalp (n = 3), auricle (n = 3), frontal (n = 4), periorbital (n = 8), temporal (n = 2), buccal (n = 7), zygomatic (n = 1), and lip areas (n = 1). Recurrence of BCC in the frontal area was detected 24 months after treatment; with a tumor infiltration depth of 15.1–20 mm, recurrence occurred at 36 months; in the multicentric variant of BCC, recurrence was noted at 24 months postoperatively.
CONCLUSION: Diagnostic criteria for BCC recurrence may include localization on the nasal skin, multicentric BCC, BCC originating from skin adnexa, and an infiltration depth of 15.1–20 mm.
Full Text

About the authors
Tatiana S. Ermakova
City Clinical Oncology Dispensary, St. Petersburg, Russia
Email: ermakova.ts@mail.ru
ORCID iD: 0000-0002-1899-554X
Oncologist
Russian Federation, St. Petersburg, RussiaEldar E. Topuzov
City Clinical Oncology Dispensary, St. Petersburg, Russia
Email: eltop@inbox.ru
ORCID iD: 0000-0002-1700-1128
SPIN-code: 1065-4191
Scopus Author ID: 6701351647
ResearcherId: O-9523-2015
MD, Dr. Sci. (Medicine), Professor
Russian Federation, St. Petersburg, RussiaVladimir A. Ershov
City Clinical Oncology Dispensary, St. Petersburg, Russia
Email: ershov415@gmail.com
ORCID iD: 0000-0002-8641-1489
MD, Dr. Sci. (Medicine)
Russian Federation, St. Petersburg, RussiaSvetlana I. Kutukova
City Clinical Oncology Dispensary, St. Petersburg, Russia
Author for correspondence.
Email: dr.s.kutukova@gmail.com
ORCID iD: 0000-0003-2221-4088
SPIN-code: 6735-6556
MD, Dr. Sci. (Medicine), Professor
Russian Federation, St. Petersburg, RussiaReferences
- Verkouteren JAC, Ramdas KHR, Wakkee M, NijstenT. Epidemiology of basal cell carcinoma: scholarly review. British Journal of Dermatology. 2017;177(2):359–372. doi: 10.1111/bjd.15321EDN: YEBMMU
- Nikiforova PO. Comparative clinical-morphological characteristics of basal cell and squamous cell skin cancer. Russian military medical academy reports. 2019;38(S1–2):31–34. EDN: HXFMAI
- Kubanov AA, Kondrakhina IN, Plakhova KI, Saitburkhanov RR. Modern understanding of the pathogenesis of basal cell skin cancer. Bulletin of Dermatology and Venereology.2021;97(5):38–51. doi: 10.25208/vdv1277 EDN: QHSTPY
- Fijałkowska M, Bonczar M, Jastrzębski I, et al. Growth rate of basal cell carcinoma: a meta-analysis and systematic review. Postepy Dermatol Alergol. 2023;40(2):220–224. doi: 10.5114/ada.2023.124795 EDN: KCZDHB
- Shulaev AV, Zaripova RN, Zhaboeva SL. Prevalence of risk factors for skin cancer and their management (literature review). Public health and health care.2020;(2);11–17. EDN: PCKOSE
- Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. Journal of the American Academy of Dermatology.2019;80(2):303–317. doi: 10.1016/j.jaad.2018.03.060 EDN: JNEWEP
- Balakhonov SI, Jordanishvili AK. Age-related features of prevalence, localization and clinical course of some forms of basal cell skin cancer of the face and head. Advances in Gerontology.2015;28(1):140–145.EDN: TMIYBZ
- Zamoresva AA. Analysis of the most common localization of basal cell carcinoma in men and women. Internauka. 2019;(16):18–19.EDN: FNRHJK
- Snarskaya ES, Ibrahim A. Superficial form of basal cell carcinoma of the skin: biological behavior, morphology and clinical variants. Russian Journal of Skin and Venereal Diseases. 2017;20(6):332–341.doi: 10.18821/1560-9588-2017-20-6-332-341EDN: XNSTFR
- Tarasenko GN, Kolenko NG, Tarasenko YuG. Basal cell skin cancer: modern clinical and diagnostic features and the role of early diagnosis. Russian Journal of Skin and Venereal Diseases.2020;23(1):12–16.doi: 10.17816/dv2020112-16 EDN: DXPPLC
- Chuprov IN. Clinical and morphological characteristics of different types of growth of basal cell skin cancer. Bulletin of the St. Petersburg University. Medicine. 2009;(1):145–150. EDN: KVNIVL
- Chuprov IN, Novitskaya TA. Morphological markers of the evolution of basal cell skin cancer. Bulletin of St. Petersburg University. Medicine. 2010;(4):116–123.EDN: NDLDNB
- Pustynsky IN,Paches AI, Kropotov MA. Remote results of cryodestruction of basal cell carcinoma of the scalp stage II. Russian journal of oncology.2013;(5):27–30.EDN: RSUFOF
- Gaidina TA, Dvornikov AS, Patsap OI, et al. Primary and multiple malignant skin tumors: melanoma and basal cell carcinoma. Bulletin of Dermatology and Venereology. 2023;99(2):48–62.doi: 10.25208/vdv1415 EDN: HYLBKJ
- Panova IE, Suslo IS, Kuchenkova IA, Arakelyan AE. Peculiarities of the course of basal cell skin cancer with primary-multiple lesion natur. Kazan Medical Journal.2013;94(4):568–571.EDN: QZIOOH
- Kaprin AD, Starinsky VV, Shakhzadova AO, editors. Malignant Neoplasms in Russia in 2021 (Incidence and Mortality). Moscow: P.A. Herzen Moscow Research Institute of Oncology, branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 2022. 252 p. (In Russ.)
- Komyakevich VV. Retrospective analysis of the results of surgical treatment of basal cell carcinoma. In: Actual Issues of Radiation and Environmental Medicine, Radiation Diagnostics, and Radiation Therapy: Collection of Materials of the VI Interuniversity Scientific and Practical Internet Conference of Students, Magisters, Postgraduate Students, and Young Scientists, Grodno, March 30, 2022. Grodno: Grodno State Medical University; 2022.Р. 157–160. (In Russ.) EDN: NVJABQ
- Titov KS, MikheevaOYu, Krasnorutsky A.V. Malignant Epithelial Tumors of the Skin: Guidelines. Moscow: Department of Health; 2019. 36 p. (In Russ.) EDN: NDEIBK
- Apalla Z, Lallas A, Sotiriou E, et al. Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017;7(2):1–6. doi: 10.5826/dpc.0702a01
- Kabanova MA, Volgin VN, Popov NM, Sachek OI, Shelepova EA. Clinical manifestations of basal cell skin cancer and the effectiveness of treatment of patients. Current problems of health care and medical statistics. 2018;(2):28–36. EDN: XSCEVV
Supplementary files
